Lipantil

Lipantil Brand names, Lipantil Analogs

Lipantil Brand Names Mixture

No information avaliable

Lipantil Chemical_Formula

C₂₀H₂₁ClO₄

Lipantil RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Lipantil fda sheet

Lipantil FDA

Lipantil msds (material safety sheet)

Lipantil MSDS

Lipantil Synthesis Reference

No information avaliable

Lipantil Molecular Weight

360.831 g/mol

Lipantil Melting Point

80.5 °C

Lipantil H₂O Solubility

0.25mg/ml at 25 °C

Lipantil State

Solid

Lipantil LogP

5.575

Lipantil Dosage Forms

Capsule; Tablet

Lipantil Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Lipantil Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Lipantil Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Lipantil side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Lipantil Patient Information